Skip to content

Uro-Team Antwerp

Active
Private limited companyfounded 2020active for 6 yearsKarel Oomsstraat 22, 2018 Antwerpen, BelgiumKBO/BCE: BE 0756.536.454
Summary

Uro-Team Antwerp has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €6,043 and a net result of €19. Equity remains stable across the filed financial years (±0.1% per year). Its solvency ranks better than 6% of 3,011 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
≈ €390,000turnover 2025, estimated
Staff
4.8 FTE
Equity
€6,043
Profit
€19
Turnover estimated from the gross margin
Financial health
77 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.5%
Structure
Largest shareholder
Dr. Christophe De Laet · 25%
2025 accounts 31 days early3 of 4 deeds summarised
Why 77raises risk1 change of registered office in 24 monthsEquity €6,043 (1.7% of total assets)lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 30-06-2026)Show the evidence

Checked score

Score 2025
77 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 15% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Weak
Solvency 27+1
equity 1.7% of total assets
Liquidity 6-37
short-term debt 92.0% · cash 4.5%
Profitability 69=
return on assets 0.0%
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%

About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,126 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1%lowest value 12-2024: 0.1%● unchanged vs 11-2024lowest value 01-2025: 0.1%● unchanged vs 12-2024lowest value 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.3%▲ +0.2 percentage points vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025 08-2025: 0.2%▼ -0.1 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.3%▲ +0.1 percentage points vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.6%▲ +0.3 percentage points vs 06-2026highest value 08-2026: 0.6%● unchanged vs 07-2026highest value 09-2026: 0.6%● unchanged vs 08-2026highest value 10-2026: 0.5%▼ -0.1 percentage points vs 09-2026
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 7% on solvency, 1% on liquidity, 13% on profitability and 39% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Figures for financial year 2025 (filed 30-06-2026)
NBB · annual accounts
raises risk · Equity €6,043 (1.7% of total assets)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 6% of 3011 sector peers (2025).
NBB · sector comparison
Position among 3011 sector peers
Solvency
better than 6%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
31 days early
2024
8 days early
2023
27 days early
2022
20 days early
2021
25 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 22 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
28-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: Dr. Demeulenaere-Van Grootel (director)Permanent representative: Ronny Demeulenaere
  2. Annual accounts filedfinancial year 2025 · abbreviated…
  3. Highest result from 2021 to 2025net €19 ▲3,226%

Key points

  • Caution: Among the weakest 7% on equitysector median €369,013 · 3,011 companies €6,043 View
  • Caution: A director leftlatest change 29-07-2026 · 1 in office 1 left View
  • Positive: Always filed on timeaccounts within the deadline every year 5 years View

By topic

Financials

Financial year
2025
Total assets
€359,634
Profit
€19
Solvency
1.7%
Total assets▼ 20.0%
Net result
20212025
Go to Financials

Board & ownership

Board
1 member
Largest shareholder
Dr. Christophe De Laet · 25%
  • Dr. Christophe De LaetDirector
Go to Board & ownership

Timeline

Events
11
Since
2022
Next accounts
by 31-07-2027
  1. 23-07-2025Annual accounts filed
  2. 02-05-2025Permanent representative: Ronny Demeulenaere
  3. 17-10-2024Appointment: Dr. Christophe De Laet BV (director)
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
13-10-2020
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Uro-Team Antwerp

What is the company number of Uro-Team Antwerp?
0756.536.454. In Belgium the VAT number is the company number with BE in front: BE 0756.536.454.
Where is Uro-Team Antwerp based?
The registered office is at Karel Oomsstraat 22, 2018 Antwerpen.Company details
What does Uro-Team Antwerp do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Uro-Team Antwerp?
Private limited company (BV).
When was Uro-Team Antwerp founded?
On 13-10-2020.
Is Uro-Team Antwerp still active?
Yes, Uro-Team Antwerp is an active enterprise in the KBO register.
How many employees does Uro-Team Antwerp have?
On average 4.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Uro-Team Antwerp?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Uro-Team Antwerp profitable?
In financial year 2025, Uro-Team Antwerp made a profit of €19.
Where can I find the annual accounts of Uro-Team Antwerp?
Uro-Team Antwerp filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Uro-Team Antwerp due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Uro-Team Antwerp

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.